Compare CGCF & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGCF | NUS |
|---|---|---|
| Founded | 2026 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.8M | 242.4M |
| IPO Year | 2026 | 1996 |
| Metric | CGCF | NUS |
|---|---|---|
| Price | $9.79 | $4.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 62.1K | ★ 401.7K |
| Earning Date | N/A | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.02% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $9.78 | $4.45 |
| 52 Week High | $9.84 | $11.67 |
| Indicator | CGCF | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 50.85 |
| Support Level | $9.78 | $4.53 |
| Resistance Level | $9.83 | $4.94 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 26.92 |
Cartesian Growth Corp IV is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.